Cargando…
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro
The emergence of SARS-CoV-2 has led to a global health crisis that, in addition to vaccines and immunomodulatory therapies, calls for the identification of antiviral therapeutics. The papain-like protease (PLpro) activity of nsp3 is an attractive drug target as it is essential for viral polyprotein...
Autores principales: | Swaim, Caleb D., Dwivedi, Varun, Perng, Yi-Chieh, Zhao, Xu, Canadeo, Larissa A., Harastani, Houda H., Darling, Tamarand L., Boon, Adrianus C.M., Lenschow, Deborah J., Kulkarni, Viraj, Huibregtse, Jon M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487320/ https://www.ncbi.nlm.nih.gov/pubmed/34632326 http://dx.doi.org/10.1016/j.isci.2021.103213 |
Ejemplares similares
-
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities
por: Swaim, Caleb D., et al.
Publicado: (2020) -
Modulation of Extracellular ISG15 Signaling by Pathogens and Viral Effector Proteins
por: Swaim, Caleb D., et al.
Publicado: (2020) -
A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ.1.1 and XBB.1.5 infection and disease in mice and hamsters
por: Ying, Baoling, et al.
Publicado: (2023) -
In vitro replication and thermodynamic studies of methylation and oxidation modifications of 6-thioguanine
por: Gu, Chunang, et al.
Publicado: (2007) -
A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters
por: Bricker, Traci L., et al.
Publicado: (2021)